Market report
Oncology drug tenders in Czechia: monthly market reports
Oncology drug tenders in Czechia in September 2026: 111 tenders published (+50% month on month, +46% year on year), estimated at €183,670,178 in total, and 127 contracts awarded (-22% month on month, -1% year on year), worth €38,596,431 (awarded value). Buyers with the most tenders: Fakultní nemocnice Ostrava (27), Fakultní nemocnice Olomouc (6) and Fakultní Thomayerova nemocnice (6); most contracts won: ROCHE s.r.o. (11), Merck Sharp & Dohme s.r.o. (7) and AbbVie s.r.o. (4). GranTender publishes a market report on oncology drug tenders in Czechia every month; 6 so far.
Read the latest report: September 2026
The highlighted bar is September 2026. Hover a bar for its figure; the table below has every value.
Every month
| Month | Tenders published | Buyers | Contracts awarded | Winners | Bids per contract |
|---|---|---|---|---|---|
| October 2026 | 80 | 7 | 68 | 9 | 1.8 |
| September 2026 | 111 | 11 | 127 | 16 | 4.0 |
| August 2026 | 74 | 7 | 162 | 14 | 2.2 |
| July 2026 | 111 | 7 | 154 | 13 | 6.3 |
| June 2026 | 74 | 7 | 186 | 15 | 4.5 |
| May 2026 | 108 | 11 | 146 | 14 | 4.8 |
| April 2026 | 91 | 10 | 191 | 13 | 2.0 |
| March 2026 | 104 | 9 | 111 | 12 | 4.0 |
| February 2026 | 103 | 10 | 104 | 13 | 3.3 |
| January 2026 | 82 | 10 | 89 | 14 | 2.0 |
| December 2025 | 84 | 13 | 107 | 22 | 1.6 |
| November 2025 | 72 | 8 | 143 | 14 | 1.8 |
| October 2025 | 118 | 9 | 166 | 15 | 1.7 |
| September 2025 | 76 | 8 | 128 | 11 | 4.0 |
| August 2025 | 96 | 9 | 115 | 10 | 5.5 |
| July 2025 | 92 | 8 | 125 | 13 | 6.2 |
| June 2025 | 86 | 7 | 146 | 9 | 3.5 |
| May 2025 | 82 | 8 | 174 | 12 | 2.5 |
| April 2025 | 88 | 6 | 179 | 10 | 2.3 |
| March 2025 | 105 | 6 | 235 | 12 | 3.7 |
| February 2025 | 85 | 9 | 115 | 12 | 7.5 |
| January 2025 | 68 | 5 | 162 | 9 | 7.5 |
| December 2024 | 92 | 8 | 95 | 14 | 8.5 |
| November 2024 | 95 | 8 | 152 | 10 | 6.3 |
| October 2024 | 123 | 9 | 160 | 15 | 6.2 |
| September 2024 | 85 | 10 | 99 | 17 | 1.4 |
| August 2024 | 78 | 7 | 129 | 11 | 3.0 |
| July 2024 | 96 | 7 | 150 | 10 | 4.3 |
| June 2024 | 71 | 7 | 100 | 11 | 4.6 |
| May 2024 | 95 | 12 | 154 | 10 | 3.2 |
| April 2024 | 126 | 7 | 169 | 13 | 11.2 |
| March 2024 | 90 | 9 | 124 | 11 | 1.3 |
| February 2024 | 108 | 8 | 82 | 12 | — |
Market reports
Other topics of Health, medical equipment and medicines
Questions and answers
- How many oncology drug tenders were published in Czechia in September 2026?
- 111 (by 11 buyers); for comparison, August 2026: 74, September 2025: 76.
- Who won the most oncology drug tenders in Czechia in September 2026?
- By number of contracts: ROCHE s.r.o. (11), Merck Sharp & Dohme s.r.o. (7), AbbVie s.r.o. (4), Avenier a.s. (4) and Takeda Pharmaceuticals Czech Republic s.r.o. (4); 16 companies won contracts in all.
- Which buyers published the most oncology drug tenders in September 2026?
- Fakultní nemocnice Ostrava (27), Fakultní nemocnice Olomouc (6), Fakultní Thomayerova nemocnice (6), Institut klinické a experimentální medicíny (4) and Oblastní nemocnice Mladá Boleslav, a.s., nemocnice Středočeského kraje (4).
- How competitive were oncology drug tenders in Czechia in September 2026?
- On average 4.0 bids per contract (66 contracts with a known number of bids); 68% of contracts had a single bid.
- What were the contracts worth in September 2026?
- €38,596,431 (awarded value, 127 contracts); median about €650,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.